arrow
R

Rudolf Uher

Dalhousie University
H指数:98
被引数:4.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Modulation of Brain Temporal Complexity During Treatment for Depression: A CAN-BIND-1 Study Report: Modulation de la complexité temporelle du cerveau pendant le traitement de la dépression: rapport de l’étude CAN-BIND-1

抑郁症治疗期间大脑时序复杂性的调节:CAN-BIND-1研究报告:抑郁症治疗期间大脑时序复杂性的调节:CAN-BIND-1研究报告

2025-12-260
PRE
Standardized EEG for multi-site biomarker-informed trials: implementation in the Canadian biomarker integration network in depression

多中心生物标志物指导试验中的标准化EEG:在加拿大抑郁症生物标志物整合网络中的应用

2025-07-110
OAAI
Predicting Relapse of Depressive Episodes During Maintenance Treatment: The Canadian Biomarker Integration Network in Depression (CAN-BIND) Wellness Monitoring in Major Depressive Disorder Study

预测维持治疗期间抑郁发作的复发:加拿大抑郁生物标志物整合网络(CAN-BIND)重度抑郁症健康监测研究

2025-04-290
PRE
Polygenic Scores and Mood Disorder Onsets in the Context of Family History and Early Psychopathology

多基因评分、心境障碍发作与家族史及早期精神病理学的关系

2025-04-160
OA
Polygenic Risk Score Analysis of Antidepressant Treatment Outcomes: A CAN-BIND-1 Study Report: Analyse des résultats du traitement antidépresseur à l'aide des scores de risque polygéniques : Rapport sur l'étude CAN-BIND-1
2025-03-010
PRE
Replication of machine learning methods to predict treatment outcome with antidepressant medications in patients with major depressive disorder from STAR*D and CAN-BIND-1 (vol 16, e0253023, 2021)

机器学习方法的复制,用于预测重度抑郁症患者使用抗抑郁药物的治疗结局,数据来源于STAR*D和CAN-BIND-1 (vol 16, e0253023, 2021)

2024-12-120
OA
Modulation of neural oscillations in escitalopram treatment: a Canadian biomarker integration network in depression study
2024-10-120
OAAI
Genome-wide meta-analysis of ascertainment and symptom structures of major depression in case-enriched and community cohorts

在病例富集和社区队列中对重度抑郁症的确定和症状结构进行全基因组荟萃分析

2024-09-262
PRE
Depression-Anxiety Coupling Strength as a predictor of relapse in major depressive disorder: A CAN-BIND wellness monitoring study report
2024-09-010
PRE
Metabolic activity of CYP2C19 and CYP2D6 on antidepressant response from 13 clinical studies using genotype imputation: a meta-analysis ( vol 14 , 350 , 2024)
2024-08-310
OAAI
Metabolic activity of CYP2C19 and CYP2D6 on antidepressant response from 13 clinical studies using genotype imputation: a meta-analysis
2024-07-191
OAAI
Integrative Genetic Variation, DNA Methylation, and Gene Expression Analysis of Escitalopram and Aripiprazole Treatment Outcomes in Depression: A CAN-BIND-1 Study

艾司西酞普兰和阿立哌唑治疗抑郁症的综合遗传变异,DNA甲基化和基因表达分析: 一项CAN-BIND-1研究

2024-06-250
PRE
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les traitements de l'humeur et de l'anxiété (CANMAT) 2023: Mise à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultes

加拿大情绪和焦虑治疗网络 (CANMAT) 2023成人重度抑郁症管理临床指南的更新: 加拿大研究和发展研究 (CANMAT) 2023: Mise à jour des lignes directrices cliniques to la priseen charge du adjeur chez les adultes

2024-05-0652
OAAI